XTL BIOPHARMACEUTICALS LTD - XTLB
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | History | Added to | 6,228 | 17 | 0.0% | 0.0% | 1 | +241 | 4.03% | Q2 2026 | Aug 11, 2026 |
| GAMMA Investing LLC | History | Reduced | 1,213 | 3 | 0.0% | 0.0% | 2 | -2,175 | -64.2% | Q2 2026 | Jul 07, 2026 |
| Noked Israel Ltd | History | Closed out | 0 | 0 | — | 0.02% | — | -49,722 | -100.0% | Q2 2026 | Aug 13, 2026 |
| SmartHarvest Portfolios, LLC | History | Closed out | 0 | 0 | — | 0.01% | — | -13,351 | -100.0% | Q2 2026 | Aug 04, 2026 |
| Tower Research Capital LLC (TRC) | History | Closed out | 0 | 0 | — | — | — | -244 | -100.0% | Q2 2026 | Aug 11, 2026 |
| UBS Group AG | History | New | 125 | 0 | — | — | — | +125 | New | Q2 2026 | Aug 13, 2026 |
| MORGAN STANLEY | History | Closed out | 0 | 0 | — | — | — | -10 | -100.0% | Q2 2026 | Aug 13, 2026 |